肿瘤出芽与肿瘤浸润淋巴细胞联合预测结直肠癌生存并建立新预后亚组
该研究对501例2005至2010年诊断的结直肠癌患者的H&E切片按ITBCC标准重新评估肿瘤出芽,并评估TILs百分比,将患者分为四组。联合分析显示四组间总生存期差异显著(P=.001),低出芽且TILs>5%组OS最长,高出芽且TILs≤5%组OS最差,联合评分还与T、N、M、L、V分期、复发和远处转移相关。
要点
- 肿瘤出芽按ITBCC标准评估,联合TILs百分比可区分结直肠癌预后亚组。
- 低出芽且TILs>5%组总生存期最长,高出芽且TILs≤5%组总生存期最差。
- 联合评分与T、N、M、L、V分期、疾病复发及远处转移相关。
核心结论
- 联合肿瘤出芽和TILs两种形态学参数可将结直肠癌进一步细分为新的预后亚组。
- 在分子病理时代,肿瘤形态学对判断肿瘤行为和预后仍具重要价值。
研究设计与样本
- 回顾性评估501例2005至2010年诊断的结直肠癌患者的H&E染色切片。
- 按ITBCC标准评估肿瘤出芽,低出芽331例,中/高出芽170例。
- 评估TILs百分比并分为四组:低出芽+TILs>5%组162例,低出芽+TILs≤5%组169例,高出芽+TILs>5%组68例,高出芽+TILs≤5%组93例。
主要发现
- 四组间总生存期差异显著(P=.001)。
- 低出芽且TILs>5%组OS最长,其次为高出芽且TILs>5%组,再次为低出芽且TILs≤5%组,高出芽且TILs≤5%组OS最差。
- 联合评分与T、N、M、L、V分期、疾病复发和远处转移相关。
关键数值与推荐
- 肿瘤出芽评估采用ITBCC标准,分为低出芽和中/高出芽。
- TILs以5%为界分为>5%和≤5%两组。
- 联合分组:低出芽+TILs>5%、低出芽+TILs≤5%、高出芽+TILs>5%、高出芽+TILs≤5%。
临床怎么用
- 在结直肠癌病理报告中可联合评估肿瘤出芽和TILs百分比,辅助预后分层。
- 按ITBCC标准评估肿瘤出芽,并以5%为界评估TILs,识别高危亚组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tumor budding is an independent prognostic factor in colorectal cancer (CRC) and has recently been well defined by the International Concensus Conference on Tumor Budding (ITBCC). Tumor-infiltrating lymphocytes (TILs) are also an issue in different human cancers and correlate with prognosis in CRC. Here we evaluate the combination of budding and TILs in CRC with regard to prognosis. Hematoxylin and eosin (H&E)-stained slides of 501 CRC patients, diagnosed between 2005 and 2010, were reevaluated for tumor budding according to the ITBCC criteria. Low (n = 331) was compared to intermediate/high budding (n = 170). The percentage of TILs was also assessed, and the following four groups were established: low budding + TILs >5% (n = 162), low budding + TILS ≤5% (n = 169), high budding + TILS >5% (n = 68), high budding + TILs ≤5% (n = 93). The combination of both markers revealed highly significant differences in overall survival (OS) between the four groups (P = .001). The low budding/>5% TILs group showed longest OS, followed by high budding/>5% TILs cases, followed by tumors with low budding/≤5% TILs. OS was worst for the high budding/≤ 5% TILs group. The combined score also correlated with T, N, M, L, Vstaging, development of disease relapse and distant metastasis. Our study shows that - even in the age of molecular pathology - it is still important to pay special attention to tumor morphology for additional information on tumor behavior and prognosis. Combining different morphological parameters of tumor and tumor environment can help to further subdivide CRC into new prognostic groups.
引用
- Lang-Schwarz C, Melcher B, Haumaier F, et al. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups. Hum Pathol. 2018. PMID: 29787819. doi:10.1016/j.humpath.2018.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。